BioVentures LLC has adopted Tradespace, an AI-driven platform built specifically for technology-transfer offices, to streamline invention disclosures and commercialization efforts across UAMS. Beginning this month, all UAMS inventors will submit new inventions through BioVentures’ new portal, powered by Tradespace, via UAMS Single Sign-On at app.tradespace.io.
Tradespace replaces the old portal with a transparent, user-friendly experience that matches the pace of translational science:
- Smarter submission forms that suggest keywords, markets, and technical classifications as you type
- Real-time tracking of disclosures and status updates throughout the evaluation process
- AI-powered market matching to help the BioVentures team identify potential licensees and collaborators faster
- A centralized dashboard that keeps inventors, administrators, and reviewers on the same page
“Adopting this new platform reflects our mission to stay at the forefront of academic innovation,” said Eric Peterson, Ph.D., President of BioVentures. “It’s about giving researchers the tools they need to partner with BioVentures and bring their cutting edge ideas to market more effectively.”
Submit your invention in minutes
Most users complete the new disclosure form in under 10 minutes. Log in and get started today: app.tradespace.io.
For questions or assistance, contact the BioVentures team at [email protected].
The post BioVentures unveils a smarter, faster way to manage invention disclosures at UAMS first appeared on Bioventures.